Cetuximab Combined With Irinotecan in First-line Therapy for Metastatic Colorectal Cancer (CRYSTAL)

Clinical trial NCT00154102 · COMPLETED

Trial details

NCT number: NCT00154102
Sponsor: Merck KGaA, Darmstadt, Germany
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Epidermal Growth Factor Receptor (EGFR) Expressing Metastatic Colorectal Cancer

Start date: 2004-05-01
Primary completion: 2006-12-01
Enrollment: 1221

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.